Is Enhabit, Inc. (EHAB) a Buy, Sell, or Hold?
NYSE : EHAB
Enhabit, Inc.
$13.8 USD
$0.01 (0.07%)
- Volume
- 652.84K
- Average Volume
- 1.65M
- Market Capitalization
- $706.91M
- P/E Ratio
- -230.00
- Dividend Yield
- 0.00%
- Price Target
- $13.80
- Year High
- $14.22
- Year Low
- $6.47
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $1.56
Company Overview
NYSE
Barbara Ann Jacobsmeyer
Medical - Care Facilities
Healthcare
EHAB
10600
US
USD
Liquidity Metrics
0.87
1.56
1.56
0.37
0.00
Sales & Valuation
$1.06B
0.66
1.28
8.74
1.58
Profitability
-$0.0906
-$4.6M
-0.30%
0.47%
-0.58%
-0.27%
P/E Metrics
-230.00
-0.69
-0.69
Analyst Price Target & Rating
$13.80
$13.80
$13.80
0/5
11 Analysts
0.00%
Financial Health Scores
1.94
5/9
$79M
$1.18B
$595M
$39.6M
Key Metrics (TTM)
$1.14B
1.07
18.80
1.56
-0.58%
-1.58%
-0.45%
11.44%
47 days
Company Executives
| Name | Title |
|---|---|
| Ryan Solomon | CFO & Principal Accounting Officer |
| Tanya R. Marion | Chief Human Resources Officer |
| Jeanne Kalvaitis | Executive Vice President of Hospice |
| Julie D. Jolley | Executive Vice President of Home Health |
| Collin McQuiddy | Senior Vice President & Chief Accounting Officer |
| Robert Okunski | Vice President of Investor Relations |
| Dylan Black | General Counsel & Secretary |
| Barbara Ann Jacobsmeyer | President, Chief Executive Officer & Director |
Poll Results
No votes yet today — be the first to share your view!
About Enhabit, Inc. (NYSE:EHAB) Stock
Enhabit, Inc. operates as a U.S.-based provider of home healthcare and hospice services. Its comprehensive home health division offers various services, such as patient education, pain management, wound care (including dressing changes), cardiac rehabilitation, infusion therapy, pharmaceutical administration, and expert observation and assessment. The company specializes in managing chronic conditions like diabetes, hypertension, arthritis, Alzheimer's disease, low vision, spinal stenosis, Parkinson's disease, osteoporosis, complex wound care, and persistent pain. Additionally, Enhabit provides tailored disease-specific plans for individuals with diabetes, congestive heart failure, those recovering from orthopedic surgery or injuries, and patients with respiratory illnesses. Complementing ... these medical offerings, licensed physical, occupational, and speech therapists deliver vital rehabilitative support. Beyond home health, Enhabit delivers extensive hospice services designed to meet the physical, emotional, spiritual, and psychosocial needs of terminally ill patients and their families. These services encompass pain and symptom control, palliative and dietary counseling, social worker visits, spiritual guidance, and bereavement support. As of March 31, 2022, Enhabit maintained a significant operational footprint, with 252 home health agencies and 99 hospice agencies spread across 34 states. Established in 2014 and headquartered in Dallas, Texas, the company was previously known as Encompass Health Home Health Holdings, Inc., officially rebranding to Enhabit, Inc. in March 2022. Enhabit, Inc. began operating as a completely independent entity on July 1, 2022.
Enhabit Home Health & Hospice Announces New Chief Executive Officer
2026-05-18 16:17:00
DALLAS--(BUSINESS WIRE)--Enhabit, Inc., a leading home health and hospice provider, today announced that Dale Clift has been appointed president and CEO, following the successful completion of the company's acquisition by Kinderhook Industries. Clift succeeds Barb Jacobsmeyer, former president and CEO of Enhabit, who previously announced her intention to step down upon the appointment of a successor. Clift brings decades of leadership experience in home health and hospice care. He previously se.
Fast-paced Momentum Stock Enhabit (EHAB) Is Still Trading at a Bargain
2026-05-14 09:55:39
If you are looking for stocks that have gained strong momentum recently but are still trading at reasonable prices, Enhabit (EHAB) could be a great choice. It is one of the several stocks that passed through our 'Fast-Paced Momentum at a Bargain' screen.
Enhabit (EHAB) Upgraded to Buy: Here's Why
2026-05-13 13:01:11
Enhabit (EHAB) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
Frequently Asked Questions
-
What is the current Enhabit, Inc. (EHAB) stock price?
-
Enhabit, Inc.(NYSE:EHAB) stock price is $13.8 in the last trading session. During the trading session, EHAB stock reached the peak price of $14.22 while $6.47 was the lowest point it dropped to. The percentage change in EHAB stock occurred in the recent session was 0.07% while the dollar amount for the price change in EHAB stock was $0.01.
-
EHAB's industry and sector of operation?
-
The NYSE listed EHAB is part of Medical - Care Facilities industry that operates in the broader Healthcare sector.
-
Who are the executives of EHAB?
-
Ryan Solomon | CFO & Principal Accounting Officer
Tanya R. Marion | Chief Human Resources Officer
Jeanne Kalvaitis | Executive Vice President of Hospice
Julie D. Jolley | Executive Vice President of Home Health
Collin McQuiddy | Senior Vice President & Chief Accounting Officer -
How many employees does EHAB have?
-
Number of EHAB employees currently stands at 10600. EHAB operates from 6688 N. Central Expressway, Dallas, TX 75206, US.
-
Link for EHAB official website?
-
Official Website of EHAB is: https://www.enhabit.com
-
How do I contact EHAB?
-
EHAB could be contacted at phone #214-239-6500 and can also be accessed through its website. EHAB operates from 6688 N. Central Expressway, Dallas, TX 75206, US.
-
How many shares of EHAB are traded daily?
-
The average number of EHAB shares traded daily for last 3 months was 1.65M.
-
What is the market cap of EHAB currently?
-
The market value of EHAB currently stands at $706.91M with its latest stock price at $13.8